Medication Adherence Is A Multifaceted Problem Requiring A Multifaceted Solution, Merck Exec Says
Addressing non-adherence to medication needs to shift from single-tactic solutions covering brief timespans to a multifaceted approach encompassing a 10- to 15-year window, Merck exec Sachin Jain tells attendees at a recent conference.
You may also be interested in...
Driving Rx Adherence In Value-Based Insurance Design Needs More Than Lower Copays – Harvard Researcher
Value-based insurance design offers the promise of offering better quality care and helping to reduce costs, but getting there will require more than trying to influence behavior by reducing copayments, Harvard’s Choudhry said in a recent webinar.
Capgemini’s calculations of potential pharmaceutical revenues if patients were fully compliant with their drug therapy regimens suggest revenues in the U.S. would be nearly 60% higher. But even small changes have sizeable revenue impact.
As themes of patient-centered outcomes and personalized medicine become more common in drug development, the concepts also are playing out in the medication adherence space, as shown in a program at Massachusetts General Hospital.